BLMH anticorps (AA 308-400) (AbBy Fluor® 350)
Aperçu rapide pour BLMH anticorps (AA 308-400) (AbBy Fluor® 350) (ABIN1392549)
Antigène
Voir toutes BLMH AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 308-400
-
Réactivité croisée
- Souris, Rat
-
Homologie
- Human,Dog,Cow,Sheep,Pig,Horse,Rabbit
-
Purification
- Purified by Protein A.
-
Immunogène
- KLH conjugated synthetic peptide derived from human BLMH
-
Isotype
- IgG
-
-
-
-
Indications d'application
-
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
Agent conservateur
- ProClin
-
Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
Date de péremption
- 12 months
-
-
- BLMH (Bleomycin Hydrolase (BLMH))
-
Autre désignation
- BLMH
-
Sujet
-
Synonyms: BH, bleomycin hydrolase, BLM hydrolase, BMH, EC 3.4.22.40, BLMH_HUMAN.
Background: Bleomycin hydrolase (BMH) is a cytoplasmic cysteine peptidase that is highly conserved through evolution, however, the only known activity of the enzyme is metabolic inactivation of the glycopeptide bleomycin (BLM), an essential component of combination chemotherapy regimens for cancer. The protein contains the signature active site residues of the cysteine protease papain superfamily. [provided by RefSeq, Jul 2008].
Antigène
-